Literature DB >> 18280215

An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate.

Nancy E Epstein1.   

Abstract

BACKGROUND CONTEXT: The artificial bone-volume expander, beta tricalcium phosphate (B-TCP, Vitoss, OrthoVita, Malvern, PA), is increasingly used to supplement autograft in posterolateral lumbar fusions.
PURPOSE: To determine fusion rates/outcomes using B-TCP/autograft. STUDY DESIGN/
SETTING: Fusion rates and outcomes were assessed for 60 predominantly geriatric patients undergoing multilevel lumbar laminectomies and 1- to 2-level noninstrumented fusions using B-TCP/autograft. PATIENT SAMPLE: Patients on average were 70 years old. OUTCOME MEASURES: Odom's criteria and Short-Form 36 (SF-36) outcomes were studied 2 years postoperatively.
METHODS: Sixty patients underwent an average of 5.4-level laminectomies with 1- to 2-level noninstrumented fusions. Based on dynamic X-ray/magnetic resonance/computed tomography (CT) studies, laminectomies addressed multilevel stenosis (60 patients), ossification of the yellow ligament (46 patients), disc herniations (20 patients), or synovial cysts (8 patients), and fusions addressed degenerative spondylolisthesis (48 patients), spondylolisthesis/lysis (2 patients), or degenerative scoliosis (10 patients). The fusion mass on each side contained half of all harvested autograft combined with one to 1.5 strips of B-TCP (saturated in 10cc of bone marrow aspirate/strip). Fusion rates were documented by two independent neuroradiologists using both dynamic X-rays, and thin-cut CT (2-dimensional/3-dimensional CT) studies obtained up to 2 years postoperatively. Odom's criteria and SF-36 outcomes were assessed over the same interval.
RESULTS: Pseudarthrosis was documented in nine (15%) patients. Two years postoperatively, Odom's criteria revealed 28 excellent, 23 good, 5 fair, and 4 poor results, whereas SF-36 data revealed improvement on 6 of 8 Health Scales in all patients.
CONCLUSIONS: A 15% pseudarthrosis rate followed multilevel laminectomy and 1- to 2-level noninstrumented posterolateral fusion using lamina autograft/B-TCP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280215     DOI: 10.1016/j.spinee.2007.11.005

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  16 in total

Review 1.  Biomaterials for Bone Regenerative Engineering.

Authors:  Xiaohua Yu; Xiaoyan Tang; Shalini V Gohil; Cato T Laurencin
Journal:  Adv Healthc Mater       Date:  2015-04-07       Impact factor: 9.933

2.  Lumbar interbody fusion with porous biphasic calcium phosphate enhanced by recombinant bone morphogenetic protein-2/silk fibroin sustained-released microsphere: an experimental study on sheep model.

Authors:  Liang Chen; Hai-Long Liu; Yong Gu; Yu Feng; Hui-Lin Yang
Journal:  J Mater Sci Mater Med       Date:  2015-02-18       Impact factor: 3.896

3.  Bone graft materials for posterolateral fusion made simple: a systematic review.

Authors:  Matthew T Morris; Sandip P Tarpada; Woojin Cho
Journal:  Eur Spine J       Date:  2018-02-14       Impact factor: 3.134

4.  A comparative evaluation of factors influencing osteoinductivity among scaffolds designed for bone regeneration.

Authors:  Erin L Hsu; Jason H Ghodasra; Amruta Ashtekar; Michael S Nickoli; Sungsoo S Lee; Samuel I Stupp; Wellington K Hsu
Journal:  Tissue Eng Part A       Date:  2013-05-01       Impact factor: 3.845

5.  The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis.

Authors:  Jeffrey A Rihn; Junaid Makda; Joseph Hong; Ravi Patel; Alan S Hilibrand; David G Anderson; Alexander R Vaccaro; Todd J Albert
Journal:  Eur Spine J       Date:  2009-05-28       Impact factor: 3.134

6.  Clinical and radiographic outcomes of extreme lateral approach to interbody fusion with β-tricalcium phosphate and hydroxyapatite composite for lumbar degenerative conditions.

Authors:  W Blake Rodgers; Edward J Gerber; Jody A Rodgers
Journal:  Int J Spine Surg       Date:  2012-12-01

7.  Preliminary documentation of the comparable efficacy of vitoss versus NanOss bioactive as bone graft expanders for posterior cervical fusion.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2015-05-07

8.  Preliminary study showing safety/efficacy of nanoss bioactive versus vitoss as bone graft expanders for lumbar noninstrumented fusions.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2015-06-25

9.  The diagnosis and management of synovial cysts: Efficacy of surgery versus cyst aspiration.

Authors:  Nancy E Epstein; Jamie Baisden
Journal:  Surg Neurol Int       Date:  2012-07-17

Review 10.  Ceramic-based bone grafts as a bone grafts extender for lumbar spine arthrodesis: a systematic review.

Authors:  Michael S Nickoli; Wellington K Hsu
Journal:  Global Spine J       Date:  2014-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.